In this study, we characterize a residualizing imaging agent, a 64Cu-labeled minibody to EMP2, and demonstrate its effectiveness in imaging human EMP2-positive endometrial tumor xenografts. The gene discussed is EMP2; the disease is endometrium neoplasm.